Press Releases
Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary...
Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection (Nuvaxovid),...
Press Releases
Thermo Fisher Scientific Launches New GMP-manufactured Cas9 Protein
As researchers using genome editing tools move from basic research to clinical settings, high-quality ancillary materials and documentation are critical. To help researchers meet stringent...
Press Releases
Takeda partners with Engitix to to develop new anti-fibrotic...
Engitix Ltd, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, entered into...
Press Releases
SGS Quay’s Microbiome Expertise Ideal For New IBD Drug...
SGS Quay Pharma is partnering on a major project to develop and commercialise an inflammatory bowel disease (IBD) candidate LIV001.
The leading contract development and manufacturing...
Press Releases
SciRhom starts CMC development of its first drug candidate...
SciRhom GmbH announced today that it has nominated the anti-iRhom2 antibody it will advance into clinical development. For this antibody, the company has closed an...
Press Releases
BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to...
BioNTech SE and Matinas BioPharma, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal...
Press Releases
Top results for Vetter in University of St. Gallen...
Vetter, a global leading contract development and manufacturing organization (CDMO), successfully participated in a lab benchmarking with its incoming goods lab in the past year....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.